A weekly schedule of docetaxel for metastatic hormone-refractory prostate cancer.
Ferrero JM, Foa C, Thezenas S, Ronchin P, Peyrade F, Valenza B, Lesbats G, Garnier G, Boublil JL, Tchiknavorian X, Chevallier D, Amiel J.
Ferrero JM, et al. Among authors: chevallier d.
Oncology. 2004;66(4):281-7. doi: 10.1159/000078328.
Oncology. 2004.
PMID: 15218295
Clinical Trial.